Production of Z-Endoxifen capsules for treatment.
Official title: NEXT DTP-22-018, GMP PRODUCTION OF 40 MG Z-ENDOXIFEN (NSC 774768) CAPSULES
Funded at Irisys, INC. · NIH-10710317 · Data updated 2026-11-12
This study is working on creating a new type of capsule called Z-Endoxifen that people can take by mouth to help treat certain health conditions, making sure it's safe and effective for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Irisys, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | June 27, 2022 |
| Project end | June 26, 2026 |
| Funding year | 2022 |
| Award (this year) | $189,535 |
| NIH project number | 75N98019D00058-0-759102200004-1 |
| Project ID | NIH-10710317 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who require oral medication for their condition and may benefit from Z-Endoxifen.
✕Less likely to help
Patients who do not require oral medication or those for whom Z-Endoxifen is not indicated may not receive any benefit from this research.
What this research studies
This research focuses on the development and manufacturing of Z-Endoxifen capsules, which are intended for oral administration. The project aims to produce a specific dosage form that can be used in clinical settings to treat certain conditions. By ensuring that these capsules are manufactured under Good Manufacturing Practices (GMP), the research emphasizes safety and efficacy for potential patients. The approach involves rigorous testing and quality control to ensure that the final product meets the necessary standards for patient use.
Why it matters
Potential benefit: If successful, this research could provide patients with a new oral treatment option that may improve their health outcomes.
How similar studies have gone: Other research has shown success in developing oral dosage forms for similar compounds, indicating a promising approach.
Where this research is happening
-
Irisys, INC.
San Diego, United States Active
Researchers
- Principal investigator: Giannini, Robert — Irisys, INC.
- Study coordinator: Giannini, Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.